Synthelis

About:

Synthelis is a biotech company specialized in production, purification, and characterization of membrane proteins.

Website: https://www.synthelis.com

Twitter/X: Synthelis

Top Investors: Rhone-Alpes Creation, Viadeo, Sud Rhone-Alpes Capital, Alpes Developpement Durable Investissement

Description:

Synthelis is a French biotech company specialized in production, purification, and characterization of membrane proteins and other difficult-to-express proteins such as ion channels, membrane transporters, GPCRs, membrane enzymes, and antigens. Based on patented cell-free technology, it provides products and services to deliver functional proteins as proteoliposomes or in a soluble detergent format. As a result it supports pharmaceutical companies, biotech companies, and academic teams in applications such as vaccine development, screening and display technologies, protein delivery, in vitro diagnostics, and structural biology. Synthelis was founded on 2011 and is based in La Tronche, France.

Total Funding Amount:

610000 EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

La Tronche, Rhone-Alpes, France

Founded Date:

2011-01-01

Contact Email:

contact(AT)synthelis.fr

Founders:

Bruno Tillier

Number of Employees:

1-10

Last Funding Date:

2014-01-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai